Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

There’s a long list of late-stage VC-backed tech companies with strong customer bases that investors hope will be enticed to ...

Toledo's profit forecast boost, Heartflow's IPO plans, research linking artificial sweeteners to less effective cancer ...

This briefing covers Heartflow's upcoming IPO aiming for a $1.32 billion valuation, research linking artificial sweeteners to ...

The Renaissance IPO ETF, which invests in newly public stocks, is up 6% this year and has soared 40% from its low point of the year in early April.

Lepu Biopharma Co. Ltd. has out-licensed two preclinical T-cell engagers to Shanghai-based newco Excalipoint in a deal worth ...

A handful of IPOs and SPACs debuted this past week, led by software unicorn Figma, which soared +250% in the best first day ...

Heartflow has filed to go public, with proceeds earmarked to repay a US$50 million loan (or US$55 million if underwriters exercise their option) and to support sales, marketing, and research and ...